Back

Obesity modifies the prognostic value of serially measured laboratory values in a real-world HFpEF cohort

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Obesity and coronary microvascular dysfunction Obesity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Ezgi Hatip Unlu

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Metabolic health modifies SYNTAX II–Based revascularization risk beyond body mass index
Professor R. Abo Fanne (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Gaps in obesity diagnosis and management among australians admitted with cardiovascular disease: a multi-centre audit
Doctor M. Lim (Gold Coast, AU)
Abstract Slides Video
Presentation thumbnail
Central adiposity outperforms body mass index in predicting coronary artery disease: a prospective comparative study
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Roles of weight change from early to middle adulthood and BMI in relation to cardiometabolic disease risks: findings from the China Kadoorie Biobank
Miss Y. Chen (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Real-world effectiveness of glp-1 receptor agonists in older adults: concordant shifts in obesity and glycaemic categories
Associate Professor R. Arbel (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Obesity and coronary microvascular dysfunction

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and prognostic impact of clinical obesity in heart failure with preserved ejection fraction: a prospective, registry cohort study
28 August 2026
thumbnail
Congress Presentation
Prognostic implication of inflammation and anorexia in older patients hospitalized for heart failure
30 August 2026
thumbnail
Congress Presentation
Non-invasive assessment of liver fibrosis with FIB-4 for risk stratification and prognosis in ambulatory heart failure
28 August 2026
thumbnail
Congress Presentation
Relationship between NT-proBNP levels and BMI on clinical outcomes in heart failure: attenuation of the obesity paradox at higher disease severity
12 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources